Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

OpenAI Launches ChatGPT Health Feature for All US Adults, Adding Apple Health and Medical Records Access

Published

on

OpenAI

OpenAI began rolling out a dedicated health feature to all adult users in the United States on Wednesday, allowing ChatGPT to securely connect to Apple Health data and electronic medical records in an effort to give users more personalized, context-aware answers to health-related questions.

The feature, called Health in ChatGPT, is now available to logged-in users 18 and older across web and iOS platforms, spanning all of the company’s subscription tiers, including Free, Go, Plus and Pro. Users can access the tool by opening Health from the sidebar within the main ChatGPT interface.

What the feature does

Health in ChatGPT allows users to securely link data from Apple Health, along with medical records from supported healthcare systems including Epic and Oracle Health, directly into their conversations with the chatbot. According to OpenAI, the feature can help users compare lab test results against prior readings, track how sleep and activity patterns change over time, monitor medication histories, and prepare for upcoming medical appointments.

Advertisement

“Health in ChatGPT now lets eligible U.S. users securely connect medical records and Apple Health to get more personalized insights and better understand their health,” OpenAI said in a blog post announcing the launch. On social media, the company reiterated the rollout in similar terms, posting, “Health in ChatGPT is starting to roll out to U.S. users. You can securely connect Apple Health and supported medical records to understand your information in context, track what has changed, and have more informed conversations.”

Electronic health record access is powered through a partnership with b.well, a company that aggregates data from roughly 2.2 million U.S. healthcare providers, allowing users to pull in information from a broad range of hospital and clinic systems rather than being limited to a single provider’s patient portal.

Why OpenAI built it this way

OpenAI said the decision to weave health context directly into the main chat interface, rather than isolating it to a separate tool entirely, stemmed from user behavior data gathered during testing. The company found that more than 70% of health-related queries happened organically within the course of everyday conversations, such as a user checking for food allergies while planning a meal, rather than through a dedicated, standalone health tab. OpenAI said the feature nonetheless appears within ChatGPT’s sidebar as its own space with separate chat history and “memories,” giving users the ability to manage their connected health context distinctly from other conversations.

Advertisement

OpenAI emphasized that more than 300 million people use ChatGPT to ask health-related questions on a weekly basis, but said that the underlying context behind those questions is often scattered across separate patient portals, medical records, fitness apps and wearable devices, making it difficult for users to see a complete picture of their health without manually piecing information together themselves.

The models behind the feature

The health feature is powered by two of OpenAI’s most recent models: GPT-5.5 Instant, available to users on the free tier, and GPT-5.6 Sol, offered to paid subscribers. OpenAI said GPT-5.5 Instant has shown meaningful improvement in recognizing when a user’s symptoms may warrant urgent medical attention, asking relevant follow-up questions, and explaining uncertainty in its responses. The company said that model performed at a level comparable to its more advanced “Thinking” models on its most challenging internal health evaluations at the time those evaluations were conducted. GPT-5.6 Sol, meanwhile, is described by OpenAI as its strongest model yet for health-related conversations.

OpenAI said it developed the feature in collaboration with more than 260 physicians practicing across 60 countries and dozens of medical specialties, using their input to help benchmark model performance against real-world clinical scenarios. The company has stressed that the tool is intended to help users feel more informed navigating everyday health questions rather than to serve as a diagnostic service or replacement for professional medical care.

Advertisement

Privacy safeguards

To address privacy concerns tied to handling sensitive medical data, OpenAI said it has implemented several layered safeguards, including strict non-training policies. According to the company, connected medical records, Apple Health data and any chat conversations that draw on that information will not be used to train OpenAI’s foundation models or to inform advertising. By default, the company said, ChatGPT will ask for a user’s permission before referencing connected medical records to generate a given response, giving users ongoing control over when and how their health data is used within the app.

A relaunch, not a first attempt

Wednesday’s broad rollout marks a relaunch of a feature OpenAI first piloted in a more limited form in January 2026. That earlier test period, according to reporting from 9to5Mac, produced what the outlet described as “lackluster results,” prompting OpenAI to spend the following months rebuilding the feature based on user feedback and improvements made to its underlying models since the start of the year. This week’s launch significantly expands access beyond that initial group of testers to include all eligible adult users across the United States.

Advertisement

Context around ongoing scrutiny

The launch comes as OpenAI faces at least one lawsuit related to health-related use of its chatbot. According to reporting, the company was sued by Scott Winters, a 55-year-old former pastor from Florida, who alleged that ChatGPT provided him with inaccurate health advice that contributed to a delay in receiving treatment for a life-threatening pulmonary embolism. OpenAI has not issued a specific public statement addressing that lawsuit in connection with this week’s Health feature launch, and the company continues to describe the tool as intended for informational purposes rather than as a substitute for professional medical evaluation and care.

With Health in ChatGPT now available broadly across the United States, OpenAI is likely to continue refining the feature based on user feedback, following the same pattern that shaped its return after January’s limited pilot. The company has not indicated a timeline for expanding the feature to international markets or additional platforms, noting specifically that Health is not yet available within Codex, OpenAI’s coding-focused product line. For now, the rollout represents one of OpenAI’s most significant pushes yet into integrating personal health data directly into everyday consumer AI conversations, a move likely to draw continued attention from both users and health care privacy advocates in the weeks ahead.

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Infosys shares fall 3% as JPMorgan downgrades stock, Jefferies cuts target after Q1 results

Published

on

Infosys shares fall 3% as JPMorgan downgrades stock, Jefferies cuts target after Q1 results
Shares of information technology major Infosys declined 2.6% to their day’s low of Rs 1,027 on the BSE on Friday after global brokerages issued bearish calls on the stock after the company trimmed the upper end of its revenue growth guidance to 1.5%-3% in constant currency, while maintaining its operating margin outlook at 20-22%.

The lower revenue guidance indicates limited demand visibility despite strong deal wins and growing AI-led revenue. The IT sector continues to face slower discretionary spending, delayed client decision-making and pressure from AI-driven productivity gains.

The company reported a 12% year-on-year (YoY) rise in consolidated net profit to Rs 7,769 crore for the first quarter of FY27, compared with Rs 6,921 crore in the year-ago quarter. Revenue from operations increased 14% YoY to Rs 48,211 crore.

Also read:
Infosys names Ashiss Kumar Dash to succeed Salil Parekh as CEO

Infosys shares: Buy, sell or hold?

JPMorgan downgraded Infosys to Neutral with a target price of Rs 1,050, saying the company’s Q1 revenue missed expectations sharply and its revenue guidance was cut significantly for the second consecutive quarter following a major miss in Q4. The brokerage said growth momentum has faced multiple setbacks, including weak demand, rising AI-led deflation, sometimes even during ongoing contracts, challenges with the Daimler contract and the termination of an Energy, Utilities, Resources and Services (EURS) contract. The new organic growth guidance of -0.2% to 1.3%, within an overall growth range of 1.5%-3%, points to a sharp slowdown that would require quarterly sequential growth of 0.4%-1.4% in a difficult environment, it added. While deal signings remain strong, AI-led deflation is keeping revenue conversion subdued, the brokerage further said.

Advertisement

Jefferies maintained its Hold recommendation on Infosys but cut the target price to Rs 1,020 from Rs 1,235, citing a worsening growth outlook that is now reflected in the stock price. The brokerage said the appointment of CEO-designate Ashiss Kumar Dash could provide some comfort around the leadership transition. Jefferies cut its estimates by 1%-3% and expects Infosys to deliver a recurring EPS CAGR of 5%.
Morgan Stanley maintained its Equal Weight rating on Infosys while cutting its target price to Rs 1,075 from Rs 1,112, implying a potential upside of 4%. The brokerage cited a weaker-than-expected quarter and a sharp reduction in guidance as the key reasons for the revision. While deal wins remained strong, revenue conversion was hurt by subdued discretionary spending. Morgan Stanley expects limited near-term valuation triggers and flat organic growth.
Citi maintained its Neutral rating on Infosys but cut the target price to Rs 1,065 from Rs 1,080. The brokerage said Q1 performance was weak after excluding the contribution from acquisitions, while deal wins and margins were key positives. However, volume growth and pricing fell short of management’s expectations, while commentary pointed to caution around discretionary spending. Citi also flagged high competitive intensity and the leadership transition as concerns, while remaining cautious on the IT sector amid AI-led deflation and the growing market share of captive centres.
Nomura has a target price of Rs 1,290 on Infosys, implying an upside of 23%. The CFO said the revised guidance reflects a volatile business environment, with the lower end factoring in further macroeconomic deterioration and the upper end assuming less improvement than previously expected. “Infosys is currently trading at an attractive valuation of 13x FY28F EPS of Rs 80.4,” it added.

Motilal Oswal Financial Services maintained its BUY rating on Infosys with a target price of Rs 1,170, implying a potential upside of 13.3% from current levels. The brokerage said Infosys lowered its FY27 revenue growth guidance amid macroeconomic uncertainty and weaker demand. It noted that Q1 revenue grew 1% quarter-on-quarter in constant currency terms, while margins remained stable. Strong deal wins, healthy cash flows and investments in artificial intelligence supported its positive view on the stock.

Read more: Infosys ADRs fall over 4% as Q1 revenue guidance cut overshadows profit growth

Nuvama retained its BUY rating on Infosys but lowered its target price to Rs 1,250 from Rs 1,650, implying an upside of over 21%. The brokerage attributed the cut to weaker-than-expected Q1FY27 growth, pricing pressure and soft demand in Europe, which also weighed on the company’s revenue guidance. It said stable margins at 21.1%, strong deal wins, increasing AI adoption and hiring plans remain positive for Infosys’ long-term growth outlook.

Emkay retained its BUY rating on Infosys and revised its target price to Rs 1,300 from Rs 1,350, indicating an upside of around 26%. The brokerage highlighted the improvement in EBIT margin to 21.1% and noted that AI Services accounted for 8.2% of Q1 revenue. While Infosys lowered its FY27 growth guidance to 1.5%-3%, Emkay identified growth in BFSI, continued AI momentum and the leadership transition as key positives.

Advertisement

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Continue Reading

Business

Dardanup Butchering Company gets approval for $55m Picton abattoir expansion

Published

on

Dardanup Butchering Company gets approval for $55m Picton abattoir expansion

Dardanup Butchering Company is one step closer to expanding its abattoir in Bunbury to double its processing facility, after a panel approved its $55 million plan.

Continue Reading

Business

A Popular Corporate Bond Fund Is Trading at a 12-Month Low

Published

on

Stocks Little Changed After Fed Decision

A fund capturing a broad swath of investment grade U.S. corporate bonds was at a level not seen in more than a year.

The fund has enjoyed an average annual return of 6.2% over the past 15 years, although over the last five years it’s down 3.7% annually on average, latest Morningstar data shows.

Continue Reading

Business

Spilt Milk Festival Reveals 2026 Lineup Headlined by Lewis Capaldi and Raye, Moves to New Geelong Home

Published

on

Spilt Milk Festival Reveals 2026 Lineup Headlined by Lewis Capaldi

Australia’s Spilt Milk festival has unveiled its full 2026 lineup, headlined by British artists Lewis Capaldi and Raye, marking Capaldi’s return to touring following a multiyear hiatus and confirming a significant relocation for the festival’s Victorian leg from Ballarat to Geelong.

Organizers revealed the complete artist bill this week following weeks of teaser announcements, with the festival set to run across four Australian cities in December.

Who’s on the bill

Lewis Capaldi and Raye will headline this year’s edition, with both artists appearing at Spilt Milk exclusively, meaning festival-goers will not be able to catch either performer at any other Australian tour stop this year. The pair are joined further down the bill by KETTAMA, Baby Keem, Maisie Peters, Remi Wolf and DMA’S, alongside a broader supporting lineup that includes Aleksiah, Borderline, F3MIII, Harry Hayes, Jigitz, Leyla Ebrahami, Miss Kaninna, Becca Hatch, Fat Papi, Pash, Samara Cyn, STÜM, The Moving Stills, The Terrys, TOBIAHS and Yes Boone.

This year’s lineup marks a notable shift in tone from 2025’s edition, which was headlined by Kendrick Lamar and Doechii. Last year’s festival drew strong reviews for its performances, with Rolling Stone Australia/New Zealand’s live review of the final Ballarat edition describing Lamar’s set as commanding even in a more relaxed mode, writing that “Kendrick in cruise control, however, is still Kendrick.”

Advertisement

Where and when

Spilt Milk 2026 will take place across four cities on consecutive weekends in December:

Saturday, Dec. 12, at Exhibition Park in Canberra; Sunday, Dec. 13, at the Gold Coast Sports Precinct; Saturday, Dec. 19, at Kardinia Park Stadium and Precinct in Geelong; and Sunday, Dec. 20, at Claremont Showground in Perth.

Presale and general ticket sales will be available through the festival’s official website, spilt-milk.com.au, with organizers indicating further ticketing details will be announced in the coming days.

Advertisement

A major relocation for the Victorian leg

The most significant change to this year’s festival is its new home in Victoria. After four editions held in Ballarat, Spilt Milk is relocating its Victorian stop to Kardinia Park Stadium and Precinct in Geelong, where it will remain based for at least the next five years, through 2030, according to the venue. The move is backed by Visit Victoria and the City of Greater Geelong.

Kicks Entertainment director and festival co-founder Ryan Sabet framed the relocation as a vote of confidence in the festival’s ability to bring major live music experiences outside of Australia’s capital cities. “Geelong is the perfect stage for the festival’s next five years,” Sabet said. “We want to thank Visit Victoria and the City of Greater Geelong for backing what Spilt Milk can do, their support means we can keep proving that a world-class festival doesn’t need to be in a capital city.”

Geelong Mayor Stretch Kontelj highlighted the anticipated economic benefits of hosting the festival, pointing to the influx of visitors it is expected to bring to the city each summer. “They’ll fill our hotels, our restaurants and our waterfront, while plenty of them will discover a city worth coming back to,” Kontelj said.

Advertisement

State Member for Geelong Christine Couzens also welcomed the move, emphasizing the value the festival could bring to young people in the region. “Bringing Spilt Milk to Geelong is a fantastic opportunity for our region, most importantly, for our young people,” Couzens said. “These kinds of experiences give them the chance to connect with friends, create lasting memories, and enjoy world-class music close to home. I’m proud that Geelong is attracting these major events.”

A festival with growing economic impact

According to figures released by Spilt Milk, the festival has contributed more than $46.7 million to the Victorian economy since 2019. Its 2025 edition alone generated an estimated $17.2 million, with roughly 34,100 attendees traveling in from outside the region. Overall festival attendance has grown substantially over the years, climbing from 28,602 attendees in 2019 to 38,729 in 2025.

A track record of major names

Advertisement

Since launching in 2016, Spilt Milk has built a reputation as one of Australia’s most closely watched regional touring festivals, having previously hosted artists including Kendrick Lamar, Doechii, Post Malone, Lorde, Childish Gambino, Flume, Steve Lacy, Dom Dolla, Latto and Khalid. The festival has also become known for consistently selling out across its host cities, with all four stops on its 2025 tour, Ballarat, Perth, Canberra and the Gold Coast, selling out.

The festival has additionally maintained a strong focus on supporting Australian artists throughout its lineups. Of the 43 acts that performed at last year’s festival, 33 were Australian, including 15 performers from Victoria and five artists based within 100 kilometers of the festival site.

A break from expectations

Ahead of this week’s official reveal, fans and festival watchers had spent weeks trying to predict the 2026 lineup based on cryptic teasers from organizers. While some predictions, including appearances from KETTAMA and Remi Wolf, proved accurate, much of the final bill, including the Capaldi and Raye headline slots, came as a surprise to those closely following the festival’s promotional campaign.

Advertisement

With the full lineup now confirmed and Geelong locked in as the festival’s new long-term Victorian home, attention now turns to ticket sales, expected to open through Spilt Milk’s official website in the coming days. Given the festival’s recent history of selling out multiple stops well ahead of their scheduled dates, organizers and fans alike are likely to be watching closely to see how quickly this year’s tickets move, particularly for the newly relocated Geelong show and the exclusive Australian appearances by both Capaldi and Raye.

Continue Reading

Business

Thai PM Outlines Six Defense Priorities for Armed Forces

Published

on

Thai PM Outlines Six Defense Priorities for Armed Forces

Prime Minister Anutin Charnvirakul met military leaders to discuss six priorities, emphasizing military readiness, border security, disaster relief, voluntary service, defense industry development, and coordination against transnational crimes.


Key Points

  • Prime Minister Anutin Charnvirakul visited the Royal Thai Armed Forces Headquarters, meeting with military and police leaders. He honored King Naresuan the Great, inspected the military honor guard, and received the Honorary Counter-Terrorism Operations Proficiency Insignia.
  • Anutin outlined six policy priorities for the armed forces, focusing on military readiness, border security, disaster relief, and promoting voluntary military service over conscription.
  • He emphasized developing Thailand’s defense industry through improved cooperation, increased domestic production, and enhanced international partnerships, urging the armed forces to utilize the Border Security Integration Center to combat transnational crimes.

Prime Minister Anutin Charnvirakul recently visited the Royal Thai Armed Forces Headquarters, where he met with the Chief of Defense Forces, service commanders, the Commissioner-General of the Royal Thai Police, and senior military officers. During the visit, he paid tribute at the King Naresuan the Great Monument, inspected the military honor guard, and received the Honorary Counter-Terrorism Operations Proficiency Insignia.

Addressing the military leadership, Anutin detailed six policy priorities for the armed forces. The goals include improving military readiness through personnel development and modern equipment, enhancing border security through the Border Security Integration Center, expanding disaster relief operations, and advancing voluntary military service as a long-term alternative to compulsory conscription.

The premier also called for continued development of Thailand’s defense industry through greater cooperation with relevant sectors, increased domestic production, and broader international partnerships. In addition, Anutin instructed the armed forces to use the Border Security Integration Center to improve coordination in combating transnational crimes, including cybercrime, human trafficking, and narcotics trafficking.

Source : Thai PM Outlines Six Defense Priorities for Armed Forces

Advertisement

Continue Reading

Business

How much money do you give for a wedding gift?

Published

on

A woman stands in the street. She wears a red head covering

You’ve been invited by the happy couple, but they’ve asked for cash – not presents. North Londoners tell us what they would do.

Continue Reading

Business

Opinion: Home-care package may need tweaks, time

Published

on

Opinion: Home-care package may need tweaks, time

OPINION: Current data suggests the Support at Home scheme isn’t yet working as intended.

Continue Reading

Business

Google’s ATLAS effort seeks to analyze AI usage

Published

on

Google's ATLAS effort seeks to analyze AI usage

As artificial intelligence use proliferates, Google, which is behind the Gemini AI platform, has announced an effort to examine how its products are being utilized.

Google asserted that “we as a society must work together to positively shape how AI impacts our lives, jobs, and economy. In order for this shared work to be effective, it is critical to have a rich understanding of how AI is being adopted and used in the economy. Society needs empirical insights and evidence-based research to inform decisions, initiatives, and actions.”

Advertisement

The company said that it “is launching the first iteration of the AI & Economy ATLAS (Activity, Task, Landscape and Adoption Study), an ongoing, large-scale, de-identified study of how people are using Google’s AI products and tools.”

ZUCKERBERG SAYS AI SHOULD EMPOWER PEOPLE, NOT REPLACE THEM, IN NEW META VISION

Google logo

Google China Tower in Zhongguancun Science Park, Beijing, China, July 15, 2026. (CFOTO/Future Publishing via Getty Images / Getty Images)

The Big Tech behemoth indicated it is using interactions with its AI for the analysis.

“ATLAS’s first dataset (v1.0) is built from 15 million aggregated and de-identified human-AI interactions across the Gemini App, AI Mode, and the Gemini API, which together are used by more than 1 billion people monthly. ATLAS v1.0 insights span more than 150 countries, 140 languages, 800 occupations, and 4,000 tasks; ATLAS is the most comprehensive look to date at how real people are using AI at scale,” Google noted.

Advertisement

GOOGLE EXPANDS MIAMI OFFICE AS CO-FOUNDERS FLEE CALIFORNIA FOR SOUTH FLORIDA

Google Midlothian Data Center

The Google Midlothian Data Center where Texas Gov. Greg Abbott and Alphabet and Google CEO Sundar Pichai were scheduled to speak Nov. 14, 2025, in Midlothian, Texas. (Ron Jenkins/Getty Images / Getty Images)

Part of a lengthy report on the analysis states that “we observe most conversational AI usage happens at home: over 86% of conversations occur outside formal work.

“In the workplace, we show that while AI adoption spans occupations covering just above 88% of U.S. employment, penetration remains shallow and overwhelmingly collaborative in nature, with end-to-end task automation limited in scope.

OPENAI SAYS AI MODEL HACKED ANOTHER COMPANY’S SYSTEMS DURING INTERNAL TEST

Advertisement
google

The Google Gemini logo is displayed on a smartphone screen. (Thomas Fuller/SOPA Images/LightRocket via Getty Images / Getty Images)

GET FOX BUSINESS ON THE GO BY CLICKING HERE

“English accounts for only about a third of global conversations, and users do not show signs of systematically abandoning their native languages for complex professional tasks, as work and non-work activities show nearly identical language distributions,” the executive summary of the report notes.

Continue Reading

Business

Leaver appointed Perth Glory CEO

Published

on

Leaver appointed Perth Glory CEO

Perth Glory has officially begun a new era off the pitch, appointing Ben Leaver as its new chief executive.

Continue Reading

Business

Meesho shares crack 5% as weak Q2 outlook spooks Street; Citi, Morgan Stanley react

Published

on

Meesho shares crack 5% as weak Q2 outlook spooks Street; Citi, Morgan Stanley react
Shares of Meesho declined as much as 5% to their day’s low of Rs 181.30 on the BSE on Friday after announcing that it expects on-year growth in net merchandise value (NMV) to dip in the July-September quarter, and plans to increase spending on acquiring new users as it builds up to the festive season.

The softer growth forecast stems from Meesho shifting its flagship Mega Blockbuster Sale to the October-December quarter this year from July-September quarter last year. The company said Q3 growth would consequently appear stronger and that comparisons should normalise when the two quarters are considered together.

The company posted a loss of Rs 133 crore for the quarter ended June 30, 2026, compared with Rs 289 crore in the same quarter last year.

Marketplace revenue from operations rose 48% YoY to Rs 3,707 crore in Q1FY27. Meesho attributed the growth to better delivery conversion, aided by lower cancellations and reduced return-to-origin rates, along with higher platform monetisation.

Advertisement

What are analysts saying?

Citi maintained its Buy rating on Meesho and raised the target price to Rs 220 (16% upside) from Rs 210. The brokerage called it a solid quarter, with growth in line with expectations and strong marketplace pricing power. Meesho successfully passed on higher fulfilment costs arising from fuel and wage inflation, while take rates and contribution margins improved despite cost pressures. Although a shift in festive season timing could weigh on near-term performance, it is expected to support the following quarter. The brokerage also raised its estimates, citing Meesho’s ability to sustain efficiency gains.

Also read: Meesho expects slower Q2 growth, to raise festive marketing spend
Morgan Stanley maintained its Equal Weight rating on Meesho with a target price of Rs 190. The brokerage described the quarter as mixed, with losses broadly in line with expectations, while revenue fell slightly short of estimates. Profitability improved at a faster pace than revenue growth, helped by better delivery conversion and logistics optimisation, which drove an expansion in contribution margins. Meesho also managed to pass on fuel and wage cost pressures. However, the merchandise value miss pointed to slower-than-expected order growth. The company is also planning higher user acquisition spending ahead of the festive season, while a shift in the timing of festive sales could make the next quarter appear softer.
JM Financial maintained its Reduce rating on Meesho with a DCF-based June 2027 target price of Rs 185, implying a downside of 2.2%. The brokerage said management expects soft growth in Q2 as the Mega Blockbuster Sale has been pushed to Q3, compared with the same period last year. Advertising and promotion spending is also expected to rise sharply in Q2 ahead of the festive season in Q3.
While JM Financial tweaked its segmental estimates after factoring in the Q1 results, its consolidated FY27-29 estimates saw only marginal changes. The brokerage remains cautious as the stock trades at elevated valuations of around 45x FY29E EV/Adjusted EBITDA, leaving limited room for execution misses.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Continue Reading

Trending

Copyright © 2025